Oral Oncology
Volume 46, Issue 5 , Pages 336-342, May 2010

Resident and bone marrow-derived mesenchymal stem cells in head and neck squamous cell carcinoma

  • Astrid De Boeck

      Affiliations

    • Laboratory of Experimental Cancer Research, Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, De Pintelaan 185, B-9000 Gent, Belgium
  • ,
  • Kishan Narine

      Affiliations

    • Division of Cardiac Surgery, Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Health Sciences Centre, 3330 Hospital Dr. NW, Calgary, AL, Canada T2N 4N1
  • ,
  • Wilfried De Neve

      Affiliations

    • Radiation Oncology, Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium
  • ,
  • Marc Mareel

      Affiliations

    • Laboratory of Experimental Cancer Research, Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, De Pintelaan 185, B-9000 Gent, Belgium
  • ,
  • Marc Bracke

      Affiliations

    • Laboratory of Experimental Cancer Research, Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, De Pintelaan 185, B-9000 Gent, Belgium
  • ,
  • Olivier De Wever

      Affiliations

    • Laboratory of Experimental Cancer Research, Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, De Pintelaan 185, B-9000 Gent, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32 9 3323008; fax: +32 9 3324991.

Received 29 October 2009; received in revised form 21 January 2010; accepted 22 January 2010. published online 11 March 2010.

Summary 

Head and neck squamous cell carcinoma (HNSCC) is a major healthcare problem worldwide affecting more than half a million patients each year. Despite considerable advances in the treatment of HNSCC, a high rate of recurrences aggravates the clinical situation and disease outcomes have only modestly improved. Recent insights show that cancer is not only a disease of the transformed epithelium but is also influenced and dependent on its stromal environment. In this review we suggest that resident and bone marrow (BM)-derived mesenchymal stem cells (MSCs) are precursors of the stroma associated with HNSCC and contribute to blood- and lymph angiogenesis, modulate the immune system and produce tumor-associated myofibroblasts. In addition, the impact of radiation therapy on the stromal reaction in HNSCC is discussed. Understanding the mechanisms of how MSCs promote invasive growth and metastasis in HNSCC and respond to cancer management strategies is of profound medical importance and will help us to design improved therapeutic protocols.

Keywords: Stromal cells, Invasion, Angiogenesis, Immunomodulation, Myofibroblast, Oral cancer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(10)00029-1

doi:10.1016/j.oraloncology.2010.01.016

Oral Oncology
Volume 46, Issue 5 , Pages 336-342, May 2010